Skip to main content

Table 3 The Odds ratio for the prevalence of CKD in patients with or without T2DM

From: The association of metabolic syndrome components and chronic kidney disease in patients with hypertension

 Model 1Model 2Model 3
 OR (95% CI)pOR (95% CI)pOR (95% CI)p
Diabetes (+)
Hypertension grades1.37 (1.12–1.68)< 0.011.38 (1.13–1.69)< 0.011.37 (1.04–1.82)0.03
Elevated TG1.79 (1.12–2.87)0.021.95 (1.21–3.15)0.012.10 (1.22–3.61)0.01
Reduced HDL-C0.81 (0.51–1.29)0.370.79 (0.49–1.27)0.330.66 (0.39–1.13)0.13
Elevated waist circumference1.43 (0.97–2.09)0.071.47 (1.00–2.17)0.051.28 (0.74–2.20)0.37
Diabetes (−)
Hypertension grades1.03 (0.91–1.17)0.641.08 (0.95–1.23)0.231.03 (0.85–1.24)0.79
Elevated TG1.35 (0.99–1.82)0.061.54 (1.12–2.12)0.011.53 (1.09–2.16)0.01
Reduced HDL-C1.29 (0.94–1.76)0.121.23 (0.89–1.71)0.211.18 (0.83–1.68)0.37
Elevated waist circumference1.30 (1.03–1.63)0.031.18 (0.93–1.49)0.171.00 (0.70–1.40)0.98
  1. Model 1: unadjusted OR; Model 2: OR adjusted for age and gender; Model 3: OR adjusted for age, gender, antihypertensive therapy and statin therapy. DM: Diabetes mellitus; FBG: Fasting blood glucose; HDL-C: High density lipoprotein-C; TG: Triglycerides